| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/09/2006 | WO2006025395A1 Drug and treating system for chronic obstructive pulmonary disease by using carrier-free cell growth factor |
| 03/09/2006 | WO2006025276A1 Remedy/preventive for ophthalmic diseases containing nattokinase |
| 03/09/2006 | WO2006025057A1 Use of il-6 in vascular complications |
| 03/09/2006 | WO2006024694A2 Peptide inhibitors of hk2 and their use |
| 03/09/2006 | WO2006024533A1 Chemokine binding activity of viral tnf receptors and related proteins |
| 03/09/2006 | WO2006024367A2 Use of nkg2d receptor/nkg2d ligand interaction blockers in the treatment of auto-immune diseases |
| 03/09/2006 | WO2006008779A8 Use of hmgb1 for wound healing |
| 03/09/2006 | WO2006005268A3 Pharmaceutical composition containing polypeptide fragments of serralysins |
| 03/09/2006 | WO2006004878A9 Attenuated herpes simplex virus type-2, vectors thereof and immunogenic compositions thereof |
| 03/09/2006 | WO2006003427A8 A protein involved in carcinoma |
| 03/09/2006 | WO2006002627A9 Chicken deoxycytidine and deoxyadenosine kinase enzymes and their use |
| 03/09/2006 | WO2005117992A3 Controlled delivery of therapeutic compounds |
| 03/09/2006 | WO2005117931A3 Glut1 transporters expressed in cancer cells |
| 03/09/2006 | WO2005082927A3 Antihypertensive peptides |
| 03/09/2006 | WO2005077976A3 Coiled-coil domains from c4b-binding protein |
| 03/09/2006 | WO2005072347A3 Inositol 1,4,5- trisphosphate receptor mutants and uses thereof |
| 03/09/2006 | WO2005063820A3 Il-7 fusion proteins |
| 03/09/2006 | WO2005058314A3 Methods for reducing the effects of stress on skin condition |
| 03/09/2006 | WO2005044993A3 Compositions and methods of using apoptosis signaling kinase related kinase (askrk) |
| 03/09/2006 | WO2004108901A3 A library of phylogenetically related sequences |
| 03/09/2006 | WO2004108077A3 Method of mitigating the adverse effects of il-2 |
| 03/09/2006 | WO2004089296A3 Improved inhibitors for the soluble epoxide hydrolase |
| 03/09/2006 | WO2004028471A3 Influenza therapeutic |
| 03/09/2006 | WO2001060320A3 Treatment of inflammation with p20 |
| 03/09/2006 | US20060053503 Cranial and vertebral defects associated with loss-of-function of Nell |
| 03/09/2006 | US20060053501 Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses |
| 03/09/2006 | US20060053498 Full-length human cdnas encoding potentially secreted proteins |
| 03/09/2006 | US20060053496 Caterpiller gene family |
| 03/09/2006 | US20060052593 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions |
| 03/09/2006 | US20060052591 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 03/09/2006 | US20060052585 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| 03/09/2006 | US20060052459 Antifungal medicaments comprising arylamidine derivatives |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052328 Connective tissue growth factor-2 |
| 03/09/2006 | US20060052326 Werner's syndrome helicase as a target for anti -HIV/AIDS therapy |
| 03/09/2006 | US20060052325 Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution |
| 03/09/2006 | US20060052323 Method to inhibit cell growth using oligonucleotides |
| 03/09/2006 | US20060052319 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes |
| 03/09/2006 | US20060052315 Cb 1/cb 2 receptor ligands and their use in the treatment of pain |
| 03/09/2006 | US20060052314 Pharmaceutical combination |
| 03/09/2006 | US20060052313 Selective dipeptide inhibitors of kallikrein |
| 03/09/2006 | US20060052312 Paclitaxel hybrid derivatives |
| 03/09/2006 | US20060052311 Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (IAP) |
| 03/09/2006 | US20060052310 Regulation of substrate activity |
| 03/09/2006 | US20060052309 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 03/09/2006 | US20060052308 Transglutaminase inhibitors and methods of use thereof |
| 03/09/2006 | US20060052307 Bone growth factor |
| 03/09/2006 | US20060052306 GRAS composition for enhanced mucosal delivery of parathyroid hormone |
| 03/09/2006 | US20060052305 Method of treating osteoporosis using intranasal parathyroid hormone |
| 03/09/2006 | US20060052304 Method for remodeling bone and related sutures |
| 03/09/2006 | US20060052303 Use of thyrotropin for regeneration of bone |
| 03/09/2006 | US20060052302 coagulants is a drug/polymer conjugates/, contains blood-coagulation factor IX covalently attached through a spacer moiety to a endcapped polyethylene glycol; blood disorders |
| 03/09/2006 | US20060052301 Splice variants of peptide YY, neuropeptide Y, pancreatic peptide Y and Amylin, and uses thereof |
| 03/09/2006 | US20060052300 Treating a condition treatable by aprotinin by administering a polypeptide having a KD1 domain with a primary structure that is at least 86% identical to the primary structure of the wild-type KD1 domain of human tissue factor pathway inhibitor-2, but does not include a KD2 or KD3 domain; cardiovascular |
| 03/09/2006 | US20060052299 Mntf peptides and compositions and methods of use |
| 03/09/2006 | US20060052298 Use of stable glutamine derivatives to improve drug absorption |
| 03/09/2006 | US20060052297 Method of up-regulating tumor antigen expression using thymalfasin |
| 03/09/2006 | US20060052296 From polyoma virus; replication-defective |
| 03/09/2006 | US20060052295 native staphylococcal enterotoxin or streptococcal pyrogenic exotoxin protein, stimulates T cell mitogensis; fusion proteins; carcinomas; combination therapy |
| 03/09/2006 | US20060052294 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 03/09/2006 | US20060052293 For therapy of obesity, hypertriglyceridemia, diet-induced insulin resistance, and/or type 2 diabetes |
| 03/09/2006 | US20060052292 Adiponectin fragments and conjugates |
| 03/09/2006 | US20060052291 Chemically-modified progenipoietin conjugates |
| 03/09/2006 | US20060052290 Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical and isotopic substitution |
| 03/09/2006 | US20060052289 Use of somatostatin analogs in sleep apnea |
| 03/09/2006 | US20060052288 Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor |
| 03/09/2006 | US20060052287 Polyethylene glycol - peptide copper complexes and compositions and methods related thereto |
| 03/09/2006 | US20060052286 Factor VII conjugates for selectively treating neovascularization disorders |
| 03/09/2006 | US20060052285 Induction of mitochondrial membrane permeabilization via the physical and functional interaction of the HIV-1 Vpr protein with the mitochondrial inner membrane protein ANT (also called adenine nucleotide translocase or ADP/ATP carrier) |
| 03/09/2006 | US20060052284 Novel peptide conjugates |
| 03/09/2006 | US20060052283 The Sperm Binding Ligand HIPRTY and Its Involvement in Embryo Cleavage |
| 03/09/2006 | US20060052282 Diagnostic and therapeutic means for pathologies associated with alpha 2 subunit of the na, k pump |
| 03/09/2006 | US20060052281 Protein s protects the nervous system from injury |
| 03/09/2006 | US20060052280 Diagnostic and therapeutic use of a golgi protein for neurodegenerative diseases |
| 03/09/2006 | US20060051867 Cell growth |
| 03/09/2006 | US20060051852 Apyrase polypeptides and nucleic acids encoding same |
| 03/09/2006 | US20060051842 Nucleic acid encoding alpha chain of human IL-11 receptor |
| 03/09/2006 | US20060051841 Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities |
| 03/09/2006 | US20060051840 Hybrid expression of neisserial proteins |
| 03/09/2006 | US20060051836 Molecules for disease detection and treatment |
| 03/09/2006 | US20060051808 Tumor related Dkk genes, proteins; host cells, vectors |
| 03/09/2006 | US20060051797 Novel testis-specific genes in avian species |
| 03/09/2006 | US20060051759 Compositions and methods relating to breast specific genes and proteins |
| 03/09/2006 | US20060051754 Transporter selectively transporting sulfate conjugate and its gene |
| 03/09/2006 | US20060051438 Herbal medicaments for the treatment of neurocerebrovascular disorders |
| 03/09/2006 | US20060051424 Compositions of oral gene therapy and methods of using same |
| 03/09/2006 | US20060051408 Microcapsules for stabilization of cosmetic, pharmaceutical or food products |
| 03/09/2006 | US20060051399 Drugs/foods comprising peptides with high glutamine content produced from wheat gluten; hypercholesterolemia, hypertriglyceridemia, fatty liver, chronic hepatits C |
| 03/09/2006 | US20060051396 Biofunctional coatings |
| 03/09/2006 | US20060051395 IFBMs to promote the specific attachment of target analytes to the surface of orthopedic implants |
| 03/09/2006 | US20060051381 Cytokine antagonists for neurological and neuropsychiatric disorders |
| 03/09/2006 | US20060051373 Particle-bound human immunodeficiency virus envelope glycoproteins and related compositions and methods |
| 03/09/2006 | US20060051367 Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences |
| 03/09/2006 | US20060051364 Purified salivary Lu. longipalpis polypeptides, and polynucleotides encoding these; vectors and host cells; inducing an immune response to sand fly saliva; diagnosing or preventing Leishmaniasis; genetic engineering |
| 03/09/2006 | US20060051357 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and or a mtor inhibitor |
| 03/09/2006 | US20060051356 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 03/09/2006 | US20060051352 CEA binding agents and compositions to reverse CEA-mediated tumorigenic effects on human cancer cells, restore sensitivity to drug induced apoptosis and uses thereof |
| 03/09/2006 | US20060051351 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
| 03/09/2006 | US20060051350 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (GITR or TNFRSF18) |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |